Report Detail
Global Exosome Diagnostics and Therapeutics Market Size, Status and Forecast 2019-2025
- RnM2989237 |
- 20 February, 2019 |
- Global |
- 98 Pages |
- QYResearch |
- Other
Exosomes play a key role in facilitating cell-to-cell communication in the cancer prognosis. It suppresses the immune function by inducing apoptosis of activated cytotoxic T cells, which enable tumor progression in the human body.
In 2018, the global Exosome Diagnostics and Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Exosome Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Exosome Diagnostics and Therapeutics development in United States, Europe and China.
The key players covered in this study
Aethlon Medical(US)
Exosome Diagnostics(US)
NanoSomix Inc.(US)
Thermo Fisher Scientific (US)
Malvern Instruments (UK)
System Biosciences(US)
NX Pharmagen (US)
Sistemic Inc(UK)
Capricor Therapeutics (US)
Exiqon A/S (Denmark)
Market segment by Type, the product can be split into
Instrument
Reagent
Software
Market segment by Application, split into
Diagnostic
Therapeutic
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Exosome Diagnostics and Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Exosome Diagnostics and Therapeutics development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Exosome Diagnostics and Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Exosome Diagnostics and Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Instrument
- 1.4.3 Reagent
- 1.4.4 Software
- 1.5 Market by Application
- 1.5.1 Global Exosome Diagnostics and Therapeutics Market Share by Application (2014-2025)
- 1.5.2 Diagnostic
- 1.5.3 Therapeutic
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Exosome Diagnostics and Therapeutics Market Size
- 2.2 Exosome Diagnostics and Therapeutics Growth Trends by Regions
- 2.2.1 Exosome Diagnostics and Therapeutics Market Size by Regions (2014-2025)
- 2.2.2 Exosome Diagnostics and Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Exosome Diagnostics and Therapeutics Market Size by Manufacturers
- 3.1.1 Global Exosome Diagnostics and Therapeutics Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Exosome Diagnostics and Therapeutics Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Exosome Diagnostics and Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Exosome Diagnostics and Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Exosome Diagnostics and Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Exosome Diagnostics and Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Exosome Diagnostics and Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Exosome Diagnostics and Therapeutics Market Size by Application (2014-2019)
5 United States
- 5.1 United States Exosome Diagnostics and Therapeutics Market Size (2014-2019)
- 5.2 Exosome Diagnostics and Therapeutics Key Players in United States
- 5.3 United States Exosome Diagnostics and Therapeutics Market Size by Type
- 5.4 United States Exosome Diagnostics and Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Exosome Diagnostics and Therapeutics Market Size (2014-2019)
- 6.2 Exosome Diagnostics and Therapeutics Key Players in Europe
- 6.3 Europe Exosome Diagnostics and Therapeutics Market Size by Type
- 6.4 Europe Exosome Diagnostics and Therapeutics Market Size by Application
7 China
- 7.1 China Exosome Diagnostics and Therapeutics Market Size (2014-2019)
- 7.2 Exosome Diagnostics and Therapeutics Key Players in China
- 7.3 China Exosome Diagnostics and Therapeutics Market Size by Type
- 7.4 China Exosome Diagnostics and Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Exosome Diagnostics and Therapeutics Market Size (2014-2019)
- 8.2 Exosome Diagnostics and Therapeutics Key Players in Japan
- 8.3 Japan Exosome Diagnostics and Therapeutics Market Size by Type
- 8.4 Japan Exosome Diagnostics and Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Exosome Diagnostics and Therapeutics Market Size (2014-2019)
- 9.2 Exosome Diagnostics and Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Exosome Diagnostics and Therapeutics Market Size by Type
- 9.4 Southeast Asia Exosome Diagnostics and Therapeutics Market Size by Application
10 India
- 10.1 India Exosome Diagnostics and Therapeutics Market Size (2014-2019)
- 10.2 Exosome Diagnostics and Therapeutics Key Players in India
- 10.3 India Exosome Diagnostics and Therapeutics Market Size by Type
- 10.4 India Exosome Diagnostics and Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Exosome Diagnostics and Therapeutics Market Size (2014-2019)
- 11.2 Exosome Diagnostics and Therapeutics Key Players in Central & South America
- 11.3 Central & South America Exosome Diagnostics and Therapeutics Market Size by Type
- 11.4 Central & South America Exosome Diagnostics and Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 Aethlon Medical(US)
- 12.1.1 Aethlon Medical(US) Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Exosome Diagnostics and Therapeutics Introduction
- 12.1.4 Aethlon Medical(US) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.1.5 Aethlon Medical(US) Recent Development
- 12.2 Exosome Diagnostics(US)
- 12.2.1 Exosome Diagnostics(US) Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Exosome Diagnostics and Therapeutics Introduction
- 12.2.4 Exosome Diagnostics(US) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.2.5 Exosome Diagnostics(US) Recent Development
- 12.3 NanoSomix Inc.(US)
- 12.3.1 NanoSomix Inc.(US) Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Exosome Diagnostics and Therapeutics Introduction
- 12.3.4 NanoSomix Inc.(US) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.3.5 NanoSomix Inc.(US) Recent Development
- 12.4 Thermo Fisher Scientific (US)
- 12.4.1 Thermo Fisher Scientific (US) Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Exosome Diagnostics and Therapeutics Introduction
- 12.4.4 Thermo Fisher Scientific (US) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.4.5 Thermo Fisher Scientific (US) Recent Development
- 12.5 Malvern Instruments (UK)
- 12.5.1 Malvern Instruments (UK) Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Exosome Diagnostics and Therapeutics Introduction
- 12.5.4 Malvern Instruments (UK) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.5.5 Malvern Instruments (UK) Recent Development
- 12.6 System Biosciences(US)
- 12.6.1 System Biosciences(US) Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Exosome Diagnostics and Therapeutics Introduction
- 12.6.4 System Biosciences(US) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.6.5 System Biosciences(US) Recent Development
- 12.7 NX Pharmagen (US)
- 12.7.1 NX Pharmagen (US) Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Exosome Diagnostics and Therapeutics Introduction
- 12.7.4 NX Pharmagen (US) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.7.5 NX Pharmagen (US) Recent Development
- 12.8 Sistemic Inc(UK)
- 12.8.1 Sistemic Inc(UK) Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Exosome Diagnostics and Therapeutics Introduction
- 12.8.4 Sistemic Inc(UK) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.8.5 Sistemic Inc(UK) Recent Development
- 12.9 Capricor Therapeutics (US)
- 12.9.1 Capricor Therapeutics (US) Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Exosome Diagnostics and Therapeutics Introduction
- 12.9.4 Capricor Therapeutics (US) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.9.5 Capricor Therapeutics (US) Recent Development
- 12.10 Exiqon A/S (Denmark)
- 12.10.1 Exiqon A/S (Denmark) Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Exosome Diagnostics and Therapeutics Introduction
- 12.10.4 Exiqon A/S (Denmark) Revenue in Exosome Diagnostics and Therapeutics Business (2014-2019)
- 12.10.5 Exiqon A/S (Denmark) Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Exosome Diagnostics and Therapeutics . Industry analysis & Market Report on Exosome Diagnostics and Therapeutics is a syndicated market report, published as Global Exosome Diagnostics and Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Exosome Diagnostics and Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
